Appendix CancerSymptoms, Doctors, Treatments, Advances & More
Learn About Appendix Cancer
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ballad Health Cancer Care
. Dr. Musgrave is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. She is also highly rated in 50 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Thrombocytopenia, Neuroendocrine Tumor, and Angiosarcoma. Dr. Musgrave is board certified in American Board Of Internal Medicine.
Vince Lombardi Cancer Clinic
Adam Siegel is a Hematologist and an Oncologist practicing medicine in Summit, Wisconsin. Dr. Siegel is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), Angiosarcoma, and Inflammatory Breast Cancer. Dr. Siegel is board certified in American Board Of Internal Medicine, Hematology.
Vince Lombardi Cancer Clinic
Demet Yasar is a Hematologist practicing medicine in Green Bay, Wisconsin. Dr. Yasar is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. She is also highly rated in 51 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). Dr. Yasar is board certified in American Board Of Internal Medicine, Hematology.
Background: Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is hyperthermic (heated) chemotherapy that washes the inside of the abdomen. CRS with HIPEC may help people with peritoneal carcinomatosis. These are tumors that have spread to the lining of the abdomen from other cancers. Researchers think they can improve the results of CRS with HIPEC treatment on these tumors by choosing the chemo...
Summary: This study will evaluate the role of mass-based response testing (MRT) to select and deliver personalized hyperthermic intraperitoneal chemotherapy (HIPEC) regimens to patients with peritoneal metastasis (PM) from high-grade appendiceal adenocarcinomas (HGAA) and colorectal cancer (CRC).